Adjuvant treatment of early colon cancer with micrometastases: Results of a national survey

Abstract

MM in colon cancer apparently influenced adjuvant treatment decisions absent known prognostic benefit. Prospective trials are needed to improve the selection of patients for systemic chemotherapy in early, node-negative colon cancer.